Medtronic (MDT) ended the recent trading session at $90.19, demonstrating a +1.05% swing from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.29%. Elsewhere, the ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...
Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...
Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).
Shares of Medtronic (MDT) traded marginally lower on Thursday after rising from a low of $80.01 from the past six trading sessions, where shares soared overall ...
The final episode of The Leaders’ Room’s season two features Robert O’Brien, country leader of Medtronic Ireland.
Medtronic (NYSE: MDT) announced today that it appointed Thierry Piéton as its new chief financial officer (CFO), effective ...
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Medtronic (MDT – Research Report). The company’s ...
The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...